Market Movers

China Vanke’s Stock Price Skyrockets to 5.40 HKD, Marking a Robust 9.09% Surge

By January 21, 2025 No Comments

China Vanke (2202)

5.40 HKD +0.45 (+9.09%) Volume: 213.35M

China Vanke’s stock price surges to 5.40 HKD, marking a significant trading session increase of +9.09% with a hefty trading volume of 213.35M, reflecting a positive year-to-date performance with a +2.08% hike. Discover the robust performance of China Vanke (2202) in the stock market today.


Latest developments on China Vanke

China Vanke (H)‘s stock price experienced significant movements today, with Hong Kong shares dropping 8% following reports of the CEO’s detention. This comes after the SZ Government reportedly held a closed-door meeting last Friday, emphasizing the importance of keeping the company’s operation stable. The Hang Seng Index also saw a spike of 223 points at midday, driven by SMIC swelling 7% and CG soaring 24% on the resumption of trading.


A look at China Vanke Smart Scores

FactorScoreMagnitude
Value5
Dividend5
Growth3
Resilience3
Momentum2
OVERALL SMART SCORE3.6

Smart Score is a compound score for the Company indicating its overall outlook. It is derived by taking an equally weighted average of underlying Factor scores computed by Smartkarma

China Vanke (H) has received high scores in both the Value and Dividend categories, indicating a positive long-term outlook for the company. With a focus on residential properties in major Chinese cities, the company’s strong value and dividend scores suggest stability and potential for growth in the real estate market.

While China Vanke (H) scored lower in Growth, Resilience, and Momentum, the overall outlook remains optimistic due to its solid performance in Value and Dividend. As a property development company with a presence in key cities like Shenzhen, Shanghai, and Beijing, China Vanke (H) is well-positioned to capitalize on the continued demand for residential properties in China.


Disclaimer: This article by Smartkarma is general in nature and based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. Note that our articles may not factor in the latest price-sensitive company announcements or qualitative material.
While all reasonable care has been taken in the preparation, Smartkarma makes no assurance about the accuracy of any generated data or content. All content is indicative only and should be independently checked for accuracy and confirmed before use. Smartkarma accepts no responsibility for any loss or damage caused as a result of any inaccuracy or error within the Lab online tools or generated data.
Have feedback on this article? Concerned about the content? Get in touch with us directly.


 

πŸ’‘ Before it’s here, it’s on Smartkarma

Sign Up for Free

The Smartkarma Preview Pass is your entry to the Independent Investment Research Network

  • βœ“ Unlimited Research Summaries
  • βœ“ Personalised Alerts
  • βœ“ Custom Watchlists
  • βœ“ Company Analytics and News
  • βœ“ Events & Webinars